chartexchange

MLTX
MoonLake Immunotherapeutics Class A
stockNASDAQ

Market OpenNov 19, 2026 2:59:12 PM EST
11.03USD+2.271%(+0.24)820,457
Pre-marketNov 19, 2026 9:28:30 AM EST
10.75USD-0.371%(-0.04)
10.64Bid11.04Ask0.40Spread
Loading…
Loading…
937.88M
Healthcare
Biotechnology
HQ
Zug, Switzerland
Previous Close
$10.79
Beta
1.64
52-Week High
$23.29 2026-06-22
52-Week Low
$9.46 2026-10-16
SMA 50
$11.68
SMA 200
$16.19
Avg. Vol 10D
1.35M
Avg. Vol 30D
1.68M
Avg. Vol 90D
1.52M
Relative Vol
0.49
75.12M
0.3000%
1,300,000
MLTX Profile

moonlake immunotherapeutics ag is a clinical-stage biopharmaceutical company leveraging revolutionary nanobody® technology to develop next-level medicines for immunologic diseases, including inflammatory skin and joint diseases.

MLTX Performance
PeriodPriceDateChangeBeta
1W12.872026-11-12-14.38%1.638
1M9.752026-10-19+13.03%2.104
3M16.742026-08-19-34.17%1.864
6M16.372026-05-19-32.68%1.419
1Y13.542025-11-19-18.61%1.643
2Y49.332024-11-19-77.66%—
5Y12.882022-04-07-14.44%0.716
MLTX Stock Summary

MoonLake Immunotherapeutics Class A (NASDAQ:MLTX) stock price today is $11.02, and today's volume is 816,660. MLTX is up 2.132% today. The 30 day average volume is 1.68M. MLTX market cap is $937.88M with 85.11M shares outstanding.